Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention

BACKGROUND: Neurotensin is involved in fatty acid and glucose metabolism and promotes the development of obesity and diabetes. These associations appear to be more pronounced in women. We investigated the association of neurotensin with long-term major adverse cardiovascular events (MACE) in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tscharre, Maximilian, Farhan, Serdar, Freynhofer, Matthias K., Leutner, Michael, Baumgartner-Parzer, Sabina, Tentzeris, Ioannis, Vogel, Birgit, Tinhofer, Florian, Rohla, Miklos, Weiss, Thomas W., Huber, Kurt, Kautzky-Willer, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957262/
https://www.ncbi.nlm.nih.gov/pubmed/35345492
http://dx.doi.org/10.3389/fcvm.2022.782602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957262/
https://www.ncbi.nlm.nih.gov/pubmed/35345492
http://dx.doi.org/10.3389/fcvm.2022.782602

Ejemplares similares